Form4insider filings, from the source

SEC Form 4 · accession 0001012975-18-000512

AILERON THERAPEUTICS INC · ALRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 7, 2018
Accepted (ET)
Jun 11, 2018 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 7, 2018S20$5.475D1,541,662D
Common StockF3,F2Jun 8, 2018S9,617$5.4032D1,532,045D
Common StockF4,F2Jun 11, 2018S18,525$5.4112D1,513,520D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses